Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Uniroid-HC Suppositories
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Cinchocaine hydrochloride, Hydrocortisone may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
What it is and what it is used for
for
Uniroid-HC suppositories contain hydrocortisone and cinchocaine hydrochloride. Hydrocortisone soothes and relieves irritations and inflammation of the skin. Cinchocaine hydrochloride, a local anaesthetic, provides pain relief. They are used to treat: internal haemorrhoids (piles), providing short-term relief of pain, irritation and associated itching around the back passage (anus). 2.
What you need to know before you take it
e Uniroid-HC suppositories
Do not use Uniroid-HC suppositories: If you are allergic to hydrocortisone, or to any other steroids If you are allergic to cinchocaine, or to any other local anaesthetics If you are allergic to any other ingredients of this medicine (listed in section 6) If you have tuberculosis If you have any kind of skin infection (e.g. thrush of the back passage, viruses affecting the skin). Warnings and precautions Talk to your doctor before using Uniroid-HC suppositories: If you have had a bad reaction to this or similar products before If you are pregnant or planning a pregnancy If you are breast-feeding. Contact your doctor if you experience blurred vision or other visual disturbances. Children and adolescents Do not use the suppositories in children under 12 years of age unless directed by the doctor. Other medicines and Uniroid-HC suppositories Tell your doctor if you are taking, have recently taken or might take any other medicines.
2/L/f/10
Uniroid-HC Suppositories PL 17736/0002
1 of 4
Some medicines may be affected by Uniroid-HC or they may affect how well Uniroid-HC will work. Some medicines may increase the effects of Uniroid-HC suppositories and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV containing cobicistat). Pregnancy and breast-feeding Do not use the suppositories if you are pregnant or breast-feeding unless advised by your doctor. If you are pregnant or breast-feeding, think you might be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. 3.
How to take it
Uniroid-HC suppositories
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is: Adults, elderly and children over 12 years: insert one suppository twice a day (morning and evening) and after each time you empty your bowels, unless your doctor has told you otherwise. Do not use the suppositories for more than 7 days. If the problem is no better, tell your doctor. Children under 12 years: this medicine is NOT suitable for children under 12 years. Administration: 1. 2. 3.
Wash your hands before and after use. Avoid excessive handling of the suppository, as it is designed to melt at body temperature. Tear one wrapped suppository from the strip and, while holding it with the tip facing upwards, peel away the foil from both sides. Insert the suppository as far as possible into the back passage (anus).
If you use more Uniroid-HC suppositories than you should If you insert too many suppositories or accidentally swallow them: 1. Tell your doctor, pharmacist or nearest hospital casualty department immediately. 2. Take the carton and any remaining suppositories with you so that people can see what you have used or taken. 3. Do this even if you feel well. If you forget to use If you forget to use a suppository, use it as soon as you remember, but if it is almost time for your next dose, skip the missed dose and continue as usual. Do not use a double dose to make up for a missed dose. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4.
Possible side effects
Like all medicines, Uniroid-HC suppositories can cause side effects, although not everybody gets them. Tell your doctor if you get the following side effect: • blurred vision or other visual disturbances 2/L/f/10
Uniroid-HC Suppositories PL 17736/0002
2 of 4
• •
an allergic reaction such as itching, pain or rash around the back passage irritation around the back passage.
Large doses and regular use may suppress the adrenal glands. This may cause complex changes in your body. If you use Uniroid-HC suppositories regularly, discuss this with your doctor. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine. 5.
How to store it
Uniroid-HC suppositories
Keep this medicine out of the reach and sight of children. Do not use this medicine after the expiry date which is stated on the foil and on the carton after "EXP". The expiry date refers to the last day of that month. Do not store above 25oC. Store in the original package. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6.
Contents of the pack and other information
What Uniroid-HC suppositories contain The active ingredients are hydrocortisone 5 mg and cinchocaine hydrochloride 5 mg. The other ingredient is hard fat. What Uniroid-HC suppositories look like and contents of the pack Uniroid-HC suppositories are off-white smooth suppositories. They are available in packs of 10 and 12 suppositories. Not all pack sizes may be marketed. Marketing Authorisation Holder Chemidex Pharma Ltd., 8a Crabtree Road, Egham, Surrey, TW20 8RN, UK. Manufacturer Famar A.V.E, Avlon Plant, 49th km National Road Athens-Lamia, 19011 Avlonas, Attiki, Greece. This leaflet was last revised in 07/2024
2/L/f/10
Uniroid-HC Suppositories PL 17736/0002
3 of 4
Frequently asked questions about Uniroid-HC Suppositories
How do I take Uniroid-HC Suppositories?
Uniroid-HC Suppositories comes as suppository. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Uniroid-HC Suppositories?
The active substance in Uniroid-HC Suppositories is cinchocaine hydrochloride, hydrocortisone.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Uniroid-HC Suppositories, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Uniroid-HC Suppositories without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: cinchocaine hydrochloride, hydrocortisone
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
Uniroid-HC Suppositories are indicated for use in the treatment of internal haemorrhoids for the short term relief of pain, irritation and associated pruritus ani.
4.2. Posology and method of administration
Posology
Adults
Treatment with Uniroid-HC Suppositories should be limited to seven days. Patients should be advised to return to their doctor if the condition persists beyond this time.
Directions for use and dosage schedule:
Peel away the foil and insert a suppository as far as possible into the anus.
One suppository to be inserted twice a day (morning and evening) and after each bowel movement, or as prescribed by the doctor.
The suppositories may be used separately or concurrently with the ointment.
Elderly patients
Dosage modifications are not required in the elderly.
Paediatric population
Uniroid-HC Suppositories are not recommended for use in children under 12 years of age unless directed by a doctor.
Method of administration
For rectal use only
4.3. Contraindications
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
This product is contraindicated in tuberculosis, anal thrush and most viral lesions of the skin including herpes simplex, vaccinia and varicella.
4.4. Special warnings and precautions for use
Recurrent or prolonged application may increase the risk of contact sensitisation particularly to cinchocaine.
As with all preparations containing topical steroids, the possibility of systemic absorption should be considered. In particular, long-term continuous therapy should be avoided in infants. Adrenal suppression can occur even without occlusion.
Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR).
4.5. Interaction with other medicinal products and other forms of interaction
Co-treatment with CYP3A inhibitors, including cobicistat-containing medicinal products, is expected to increase the risk of systemic side-effects.
The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic corticosteroid side-effects.
4.6. Fertility, pregnancy and lactation
Pregnancy
In pregnant animals, administration of corticosteroids can cause abnormalities of foetal development. The relevance of this finding to human beings has not been established. However, topical steroids should not be used extensively in pregnancy, i.e. in large amounts or for long periods.
Breastfeeding
Hydrocortisone may pass into human breast milk. Given the possible maternal systemic absorption and lack of data, Uniroid-HC Suppositories should preferably not be used during lactation unless the potential benefits to the mother outweigh the potential risks, including those to the breastfed child.
4.7. Effects on ability to drive and use machines
Uniroid-HC Suppositories have no or negligible influence on the ability to drive and use machines.
4.8. Undesirable effects
The frequencies of adverse events are ranked according to the following convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data).
Endocrine disorders
Not known: Adrenal suppression (see section 4.4).
Eye disorders
Not known: Chorioretinopathy, vision blurred (see section 4.4).
Gastrointestinal disorders
Not known: Anorectal discomfort.
Skin and subcutaneous tissue disorders
Not known: Urticaria, rash (see section 4.4).
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4.9. Overdose
Not applicable to a product with this route of administration.
🇷🇴 Known in Romania as
Medicines sold in Romania with the same active substance: Cunoscut în România ca
⚠ Not the same combination. This medicine contains Cinchocaine hydrochloride, Hydrocortisone. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
- SOFTACORT 3,35 mg/ml prescription partial — not the same combinationHYDROCORTISONUM · eye / ear / nose
- HIDROCORTIZON ATB 10 mg prescription partial — not the same combinationHYDROCORTISONUM · taken by mouth
- HIDROCORTIZON FITERMAN 10 mg/g prescription partial — not the same combinationHYDROCORTISONUM · skin / topical
- HIDROCORTIZON ZENTIVA 19,6 mg/5 ml prescription partial — not the same combinationHYDROCORTISONUM · injection / infusion
- HIDROCORTIZON ROMPHARM 100 mg prescription partial — not the same combinationHYDROCORTISONUM · injection / infusion
- HYDROCORTISONE SUCCINAT SODIC EIPICO 100 mg prescription partial — not the same combinationHYDROCORTISONUM · injection / infusion
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
🇵🇱 Known in Poland as
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Not the same combination. This medicine contains Cinchocaine hydrochloride, Hydrocortisone. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
- Proktosedon partial — not the same combinationHydrocortisonum + Cinchocaini hydrochloridum + Esculinum + Neomycini sulfas · rectal / vaginal
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
💬 Ask about this leaflet
Ask anything about Uniroid-HC Suppositories. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.